Lung Cancer Patients’ Profile in Dr Soetomo General Hospital Surabaya 2016 - 2017: Newest Report

Sita Ro'yul Aini, Laksmi Wulandari, Susilowati Andajani

Abstract views = 526 times | downloads = 292 times


Introduction: Lung cancer is the leading cause of cancer death in the world, its 5 years survival rate is only 17%, whereas its incidence is the first most in men and third in women.

Methods: This research was a descriptive observational study. The samples were 240 patients of lung cancer in Poly Oncology Dr. Soetomo General Hospital Surabaya 2016-2017. Sampling technique was non-random sampling (consecutive sampling). The variables were: age, sex, smoking habits, type of lung cancer, type of mutation, stage, symptoms, Vena Cava Superior syndrome, and therapy. The data analyzed were analyzed descriptively.

Results: Patients mostly at age 51-55 and 56-60 years old (18% each). Ratio men and women are 1,7:1. In all type of lung cancer, men are dominant than women and mostly patients is active smoker. Ephidermal Growth Factor Receptor (EGFR) mutation found in adenosquamous (75%) and adenocarcinoma (65%). Most patients diagnosed at advance stage. Most symptoms are cough (70.4%), dyspnoea (50%), and chest pain (49.2%). Vena Cava Superior Syndrome (VCSS) found in adenocarcinoma (75%) and squamous cell carcinoma (25%). In adenocarcinoma and adenosquamous, patients commonly got targeted therapy.

Conclusion: Lung cancer patients: 1) Men tend to be exposed to younger than women, 2) ratio men and women is 1.7:1 and most type in lung cancer is adenocarcinoma 3) mostly patients is active smoker, 4) EGFR mutation tent to be in women with adenocarcinoma, 5) most stage is stage IV, 6) most symptoms is cough, 7) Vena Cava Superior Syndrome is in adenocarcinoma (75%) and carcinoma cell squamous (25%), 8) patients’ therapy mostly with targeted therapy followed by chemotherapy.

Full Text:



Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2014;136(5):E359-E386.

World Health Organization – Cancer Country Profiles 2014 [Internet]. 2014 [cited 17 May 2017]. Available from:

Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Kedokteran Kanker Paru. 2015.

Dela Cruz C, Tanoue L, Matthay R. Lung Cancer: Epidemiology, Etiology, and Prevention. Clinics in Chest Medicine. 2011;32(4):605-644.

Cheng T, Cramb S, Baade P, Youlden D, Nwogu C, Reid M. The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics. Journal of Thoracic Oncology. 2016;11(10):1653-1671.

CDC - What Is Lung Cancer? [Internet]. 2018 [cited 23 November 2018]. Available from:

Ridge C, McErlean A, Ginsberg M. Epidemiology of Lung Cancer. Seminars in Interventional Radiology. 2013;30(02):093-098.

Youlden D, Cramb S, Baade P. The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends. Journal of Thoracic Oncology. 2008;3(8):819-831.

Midha A, Dearden S, McCormack R. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII). Am J Cancer Res Am J Cancer Res 2015;5(9):2892-2911 [Internet]. 2015 [cited 23 November 2018];. Available from: /ISSN:2156-6976/ajcr0013308

Miller K, Siegel R, Lin C, Mariotto A, Kramer J, Rowland J et al. Cancer treatment and survivorship statistics, 2016. CA: A Cancer Journal for Clinicians. 2016;66(4):271-289.

Nickloes T. Superior Vena Cava Syndrome: Background, Pathophysiology, Etiology [Internet]. 2018 [cited 23 November 2018]. Available from:

Tan W. Non-Small Cell Lung Cancer Clinical Presentation: History, Physical Examination [Internet]. 2018 [cited 23 November 2018]. Available from:


  • There are currently no refbacks.

Copyright (c) 2019 JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga




Creative Commons License

JUXTA (p-ISSN: 1907-3623, e-ISSN: 2684-9453) is licensed under Creative Commons Attribution-ShareAlike 4.0 International License.

 View JUXTA Stats